View on Pubmed.gov 40319309 | View on doi.org 10.1186/s13075-...
Recent advances in omics and the integration of multi-omics in osteoarthritis research.
- Department of Cell Biology, Van Andel Research Institute, 333 Bostwick Ave NE, Grand Rapids, MI, 49503, USA.
- Department of Cell Biology, Van Andel Research Institute, 333 Bostwick Ave NE, Grand Rapids, MI, 49503, USA. tao.yang@vai.org.
Abstract
Osteoarthritis (OA) is a complex disorder driven by the combination of environmental and genetic factors. Given its high global prevalence and heterogeneity, developing effective and personalized treatment methods is crucial. This requires identifying new disease mechanisms, drug targets, and biomarkers. Various omics approaches have been applied to identify OA-related genes, pathways, and biomarkers, including genomics, epigenomics, transcriptomics, proteomics, and metabolomics. These omics studies have generated vast datasets that are shaping the field of OA research. The emergence of high-resolution methodologies, such as single-cell and spatial omics techniques, further enhances our ability to dissect molecular complexities within the OA microenvironment. By integrating these multi-layered datasets, researchers can uncover central signaling hubs and disease mechanisms, ultimately facilitating the development of targeted therapies and precision medicine approaches for OA treatment.
References
Br J Radiol. 2018 May;91(1085):20170349
Nat Commun. 2022 May 4;13(1):2447
Platelets. 2017 May;28(3):263-271
Hum Mol Genet. 2015 Oct 15;24(R1):R93-R101
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not Applicable. Competing interests: The authors declare no competing interests.
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
Substances
Copyright
© 2025. The Author(s).